Orchid Pharma Limited · NSE:ORCHPHARMA
Orchid Pharma — Q3 FY24 Earnings Presentation
9 slides from Orchid Pharma's earnings presentation, Feb 9, 2024
Slide 1: Investors Presentation cover letter to NSE and BSE
February 08, 2024 National Stock Exchange of India Limited, BSE Limited Exchange Plaza, Bandra Kurla Complex Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai-400051 Dalal Street, Fort, Mumbai-400001 Symbol: ORCHPHARMA Scrip Code: 524372 Subject: Investors Presentation for the Quarter 3rd ended on Decem
Slide 2: Orchid Pharma Limited - Financials Oct-Dec 2023
Orchid Pharma Limited Financials Oct-Dec 2023
Slide 3: Financial Highlights Q3 FY24
Financial Highlights Q3 FY24 38% 92% 355% 355% * Compared with 9M FY23
Slide 4: Financial Highlights
Financial Highlights (Rs/Crore) Q3-2023 Q3-2022 Change % 9M-31st Dec’23 9M-31st Dec’22 Change % Sales 220.6 159.8 +38% 602.3 456.0 +32% Other Income 7.4 8.9 17.5 17.7 COGS 121.9 95.6 356.4 265.7 Employee Exp 18.7 16.7 52.1 49.0 Other Exp 44.1 33.8 112.1 97.4 EBITDA 43.3 22.6 +92% 99.3 61.6 +61% % to
Slide 5: Financial Highlights
Financial Highlights Growth Q3 23-24 Q2 23-24 Q1 23-24 9ME 23-24 Criteria Turnover 38% 20% 40% 32% EBIDTA 92% 34% 57% 61% PBT 355% 712% 177% 676% PAT 355% 712% 177% 676% * YoY Comparison with FY23
Slide 6: Turnover (In Cr.)
Turnover (In Cr.) 700.0 602.3 600.0 500.0 456.0 400.0 376.7 300.0 220.6 200.0 159.3 159.8 100.0 - Dec-21 Dec-22 Dec-23 9ME Dec Q3 -Dec
Slide 7: P&L Analysis – Exp. % to sales 9M
P&L Analysis – Exp. % to sales 9M 30.0% 25.0% 24.0% 21.4% 20.0% 18.6% 15.0% 12.3% 10.7% 10.0% 8.6% 5.0% 0.0% Dec-21 Dec-22 Dec-23 Emp Benefit Other Exp
Slide 8: EBIDTA & PAT as % to sales 9ME Dec
EBIDTA & PAT as % to sales 9ME Dec 20.0% 16.5% 15.0% 13.5% 9.0% 10.2% 10.0% 5.0% 0.0% -2.3% -5.0% -10.0% -14.3% -15.0% -20.0% Dec-21 Dec-22 Dec-23 EBITDA PAT
Slide 9: Thanks
Thanks